Notice of Annual General Meeting
Released
Released
Announcement PDF
30 October 2023
Dear Shareholder,
Notice of Annual General Meeting
Please be aware that Delorean Corporation Limited (“Delorean” or “the Company”) has today
released a Notice of Meeting (NoM) for its Annual General Meeting of Shareholders to be held on
30 November 2023 at 11:00am Australia Western Standard Time.
In accordance with the section 110D of the Corporations Act 2001 (Cth), the Company will not be
dispatching physical copies of the NoM unless a shareholder has elected to receive notices of
meeting in hard copy pursuant to section 110E, or who otherwise requests a hard copy. Instead, a
copy of the NoM can be viewed and downloaded online at the following link:
https://deloreancorporation.com.au/announcements/
Should you wish to receive a physical copy of the NoM, please contact the Company Secretary via
email to david.mcarthur@deloreancorporation.com.au or via telephone to +61 8 6147 7575.
A copy of the proxy form is enclosed. Proxy votes may be lodged by the following methods:
-
-
By mail to Unit 1, 1205 Hay Street, West Perth, WA 6005; or
By email to the Company Secretary.
Your proxy voting instruction must be received by 11:00am (AWST) on 28 November 2023, being
not less than 48 hours before the commencement of the Meeting. Any proxy voting instructions
received after that time will not be valid for the Meeting.
The Notice of Meeting is important and should be read in its entirety. If you are in doubt as to the
course of action you should follow, you should consult your financial adviser, lawyer, accountant or
other professional adviser.
Yours sincerely
David McArthur
Company Secretary
Delorean Corporation Ltd | ACN 638 111 127
Deloreancorporation.com.au |Unit 1 Ground Floor, 1205 Hay Street WEST PERTH WA 6005 | PH: 08 6147 7575
DELOREAN CORPORATION LIMITED
ACN 638 111 127
NOTICE OF ANNUAL GENERAL MEETING
PROXY FORM
AND
EXPLANATORY STATEMENT
Date of Meeting
30 November 2023
Time of Meeting
11:00 am (AWST)
Place of Meeting
Level 32, Exchange Tower
2 The Esplanade
Perth, WA
The business of the Meeting affects your shareholding and your vote is important.
This Notice should be read in its entirety. If Shareholders are in doubt as to how they should vote, they should seek advice
from their professional advisers prior to voting.
The Directors have determined pursuant to Regulation 7.11.37 of the Corporations Regulations 2001 (Cth) that the
persons eligible to vote at the Meeting are those who are registered Shareholders at 4:00pm AWST on 28 November
2023.
DELOREAN CORPORATION LIMITED
ACN 638 111 127
NOTICE OF ANNUAL GENERAL MEETING
Notice is hereby given that the Annual General Meeting of shareholders of Delorean Corporation Limited
("Company") will be held at 11:00 am (AWST) on 30 November 2023, at Level 31, Exchange Tower, 2 The
Esplanade, Perth, WA.
In order to determine voting entitlements, the register of Shareholders will be closed at 4:00 pm (AWST) on 28
November 2023.
An Explanatory Statement containing information in relation to each of the Resolutions to be put to the meeting
accompanies this Notice.
AGENDA
To consider and, if thought fit, to pass the following Resolutions.
ORDINARY BUSINESS
Financial Statements and Reports
To receive and consider the annual financial report for the Company for the financial year ended 30 June 2023
together with the declaration of the Directors, the Director’s report, the Remuneration Report and the auditor's
report.
Resolution 1: Adoption of the Remuneration Report
To consider and, if thought fit, to pass, with or without amendment, the following resolution as a non-binding
resolution:
“That, for the purposes of section 250R(2) of the Corporations Act and for all other purposes,
approval is given for the adoption of the Remuneration Report contained within the Company’s
annual financial report for the financial year ended 30 June 2023.”
Note 1: The vote on this resolution is advisory only and does not bind the Directors of the Company.
Note 2: If 25% or more of votes that are cast are voted against the adoption of the Remuneration Report at two
consecutive annual general meetings, Shareholders will be required to vote at the second of those annual general
meetings on a resolution (a "spill resolution") at another meeting be held within 90 days at which all of the
Company's Directors (other than the Managing Director) must stand for re-election. The remuneration report was
adopted by greater than 75% of the votes cast at the 2022 AGM.
Voting Prohibition Statement:
A vote on this Resolution 1 must not be cast (in any capacity) by or on behalf of any of the following persons:
(a)
a member of the Key Management Personnel, details of whose remuneration are included in the
Remuneration Report; or
(b)
a Closely Related Party of such a member.
(collectively, a "Prohibited Voter").
1 |
However, a Prohibited Voter may cast a vote on this Resolution 1 as a proxy if the vote is not cast on behalf of a
person described above and either:
(a)
the Prohibited Voter is appointed as a proxy by writing that specifies the way the proxy is to vote on the
Resolution; or
(b)
the Prohibited Voter is the Chair and the appointment of the Chair as proxy:
(i)
does not specify the way the proxy is to vote on this Resolution; and
(ii)
expressly authorises the Chair to exercise the proxy even if the Resolution is connected directly or
indirectly with the remuneration of a member of the Key Management Personnel for the Company,
or if the Company is part of a consolidated entity, for the entity.
Resolution 2: Re-Election of Director – Mr Steve Gostlow
To consider, and if thought fit, to pass, with or without amendment, the following resolution as an ordinary
resolution:
“That Mr Steve Gostlow, a Director, who retires by rotation in accordance with Article 14.2 of the
Company’s Constitution, ASX Listing Rule 14.4 and for all other purposes, and being eligible is reelected a director of the Company.”
Resolution 3: Adoption of Employee Incentive Securities Plan
To consider, and if thought fit, to pass, with or without amendment, the following resolution as an ordinary
resolution:
“That, for the purposes of ASX Listing Rule 7.2 (Exception 13(b)) and for all other purposes, approval
is given for the Company to adopt an employee incentive scheme titled Employee Incentive Securities
Plan and for the issue of Securities under that plan, on the terms and conditions set out in the
Explanatory Statement.”
Voting Prohibition Statement:
A person appointed as proxy must not vote, on the basis of that appointment, on this Resolution if:
(a) the proxy is either:
(i)
a member of the Key Management Personnel; or
(ii)
a Closely Related Party of such a member; and
(b) the appointment does not specify the way the proxy is to vote on this Resolution.
However, the above prohibition does not apply if:
(a) the proxy is the Chair; and
(b) the appointment expressly authorises the Chair to exercise the proxy even though this Resolution is
connected directly or indirectly with remuneration of a member of the Key Management Personnel.
Voting Exclusion Statement:
In accordance with ASX Listing Rule 14.11, the Company will disregard any votes cast in favour of the Resolution
by a person who is eligible to participate in the employee incentive scheme or an associate of that person or those
persons.
However, this does not apply to a vote cast in favour of the Resolution by:
2 |
(a) a person as a proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with
the directions given to the proxy or attorney to vote on the Resolution in that way; or
(b) the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with
a direction given to the Chair to vote on the Resolution as the Chair decides; or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary
provided the following conditions are met:
(i)
the beneficiary provides written confirmation to the holder that the beneficiary is not excluded
from voting, and is not an associate of a person excluded from voting, on the Resolution; and
(ii)
the holder votes on the Resolution in accordance with directions given by the beneficiary to the
holder to vote in that way.
Resolution 4: Approval of 7.1A Mandate
To consider, and if thought fit, to pass, with or without amendment, the following resolution as a special
resolution:
“That, for the purpose of ASX Listing Rule 7.1A and for all other purposes, approval is given for the
issue of Equity Securities totalling up to 10% of the issued capital of the Company at the time of
issue, calculated in accordance with the formula prescribed in ASX Listing Rule 7.1A.2 and on the
terms and conditions set out in the Explanatory Statement accompanying this Notice of Meeting.”
Important note: The proposed recipients of any Equity Securities under the 10% Placement Capacity are not as
yet known or identified. In these circumstances (and in accordance with the note set out in ASX Listing Rule 14.11.1
relating to ASX Listing Rules 7.1 and 7.1A), for a person’s vote to be excluded, it must be known that that person
will participate in the proposed issue. Where it is not known who will participate in the proposed issue (as is the
case in respect of any Equity Securities issued under the 10% Placement Capacity), Shareholders must consider
the proposal on the basis that they may or may not get a benefit and that it is possible that their holding will be
diluted, and there is no reason to exclude their votes.
By Order of the Board
David McArthur
Company Secretary
Dated: 16 October 2023
3 |
ENTITLEMENT TO ATTEND AND VOTE
The Company may specify a time, not more than 48 hours before the Meeting, at which a “snap-shot” of
Shareholders will be taken for the purposes of determining Shareholder entitlements to vote at the Annual
General Meeting.
The Company’s Directors have determined that all Shares of the Company that are quoted on ASX at 4:00pm
(AWST) on 28 November 2023 shall, for the purposes of determining voting entitlements at the Annual General
Meeting, be taken to be held by the persons registered as holding the Shares at that time.
VOTING IN PERSON
To vote in person, attend the Meeting at the time, date and place set out above.
VOTING BY PROXY
To vote by proxy, please complete and sign the enclosed Proxy Form and return by the time and in accordance
with the instructions set out on the Proxy Form.
In accordance with section 249L of the Corporations Act, Shareholders are advised that:
(a)
each Shareholder has a right to appoint a proxy;
(b)
the proxy need not be a member of the Company; and
(c)
a Shareholder who is entitled to cast two or more votes may appoint two proxies and may specify the
proportion or number of votes each proxy is appointed to exercise. If the member appoints two proxies
and the appointment does not specify the proportion or number of the member’s votes, then in
accordance with section 249X(3) of the Corporations Act, each proxy may exercise one-half of the votes.
The enclosed Proxy Form provides further details on appointing proxies and lodging Proxy Forms.
CORPORATE REPRESENTATIVE
A Shareholder that is a corporation may appoint an individual to act as its corporate representative to vote at the
Meeting in accordance with section 250D of the Corporations Act. Any corporation wishing to appoint an
individual to act as its representative at the Meeting should provide that person with a certificate or letter
executed in accordance with the Corporations Act authorising him or her to act as that company’s representative.
The authority may be sent to the Company and/or Share Registry in advance of the Meeting or handed in at the
Meeting when registering as a corporate representative. A ‘Certificate of Appointment of Corporate
Representative’ is enclosed if required.
ENQUIRIES
Shareholders are invited to contact the Company Secretary, Mr David McArthur, on +61 8 6147 7575 if they have
any queries in respect of the matters set out in this document.
4 |
DELOREAN CORPORATION LIMITED
ACN 638 111 127
EXPLANATORY STATEMENT
This Explanatory Statement is intended to provide Shareholders with sufficient information to assess the merits
of the Resolutions contained in the accompanying Notice of Annual General Meeting (“Notice”) of the Company.
The Directors of the Company (“Directors”) recommend Shareholders read this Explanatory Statement in full
before making any decision in relation to the Resolutions.
The following information should be noted in respect of the various matters contained in the accompanying
Notice.
FINANCIAL STATEMENTS AND REPORTS
The business of the Annual General Meeting will include receipt and consideration of the annual financial report
of the Company for the financial year ended 30 June 2023, together with the declaration of the Directors, the
Directors’ report, the Remuneration Report and the auditor's report.
A copy of the Company’s 2023 Annual Report is available on the Company’s ASX platform (ASX:DEL) and on the
website deloreancorporation.com.au/investor-centre/. Alternatively, a hard copy will be made available upon
request.
The Company’s auditor, RSM, will be present at the Annual General Meeting and Shareholders will have the
opportunity to ask the auditor questions in relation to the conduct of the audit, the auditor’s report, the
Company’s accounting policies, and the independence of the auditor.
In addition to taking questions at the Meeting, written questions to the Chair about the management of the
Company, or to the Company’s auditor about:
(a)
the preparation and content of the auditor’s report;
(b)
the conduct of the audit;
(c)
accounting policies adopted by the Company in relation to the preparation of the Annual Financial
Statements; and
(d)
the independence of the auditor in relation to the conduct of the audit,
may be submitted no later than 5 business days before the meeting date to the Company Secretary.
RESOLUTION 1: Adoption of Remuneration Report
General
The Corporations Act requires that at a listed company’s Annual General Meeting, a resolution that the
Remuneration Report be adopted must be put to the Shareholders. However, such a resolution is advisory only
and does not bind the Directors or the Company.
The Remuneration Report sets out the Company’s remuneration arrangements for the Directors and senior
management of the Company. The Remuneration Report is part of the Directors’ report contained in the annual
financial report of the Company for a financial year.
The chair of the meeting must allow a reasonable opportunity for its shareholders to ask questions about or make
comments on the Remuneration Report at the Annual General Meeting.
5 |
Voting consequences
A company is required to put to its shareholders a resolution proposing the calling of another meeting of
shareholders to consider the appointment of directors of the company (Spill Resolution) if, at consecutive annual
general meetings, at least 25% of the votes cast on a remuneration report resolution are voted against adoption
of the remuneration report and at the first of those annual general meetings a Spill Resolution was not put to vote.
If required, the Spill Resolution must be put to vote at the second of those annual general meetings.
If more than 50% of votes cast are in favour of the Spill Resolution, the company must convene a shareholder
meeting (Spill Meeting) within 90 days of the second annual general meeting.
All of the Directors of the Company who were in office when the Directors' report (as included in the Company’s
annual financial report for the most recent financial year) was approved, other than the Managing Director of the
Company, will cease to hold office immediately before the end of the Spill Meeting but may stand for re-election
at the Spill Meeting.
Following the Spill Meeting those persons whose election or re-election as Directors of the company is approved
will be the Directors of the Company.
Previous voting results
Greater than 75% of shares were voted in favour of the adoption of the remuneration report at the 2022 AGM.
Proxy restrictions
Shareholders appointing a proxy for Resolution 1 should note the following:
(a)
If you appoint a member of the Key Management Personnel (other than the Chair) as your proxy
If you elect to appoint a member of the Key Management Personnel (other than the Chair) whose
remuneration details are included in the Remuneration Report, or a Closely Related Party of that member,
you must direct the proxy how they are to vote. Undirected proxies granted to these persons will not be
voted and will not be counted in calculating the required majority if a poll is called on this Resolution.
(b)
If you appoint the Chair as your proxy
If you elect to appoint the Chair where he/ she is also a member of the Key Management Personnel whose
remunerations details are included in the Remuneration Report, or a Closely Related Party of such a
member, you must direct the Chair how they are to vote. Undirected proxies granted to these persons
will be voted in favour of all Resolutions.
(c)
If you appoint any other person as your proxy
You do not need to direct your proxy how to vote, and you do not need to tick any further
acknowledgement on the Proxy Form. Undirected proxies granted to these persons will be voted at their
discretion.
RESOLUTION 2: Re-election of Director – Steve Gostlow
ASX Listing Rule 14.4 provides that a Director of an entity must not hold office (without re-election) past the third
Annual General Meeting following the Director’s appointment or 3 years, whichever is longer.
Clause 14.2 of the Company’s Constitution requires that at every Annual General Meeting of the Company onethird of the Directors excluding the Managing Director (rounded up to the nearest whole number) shall retire from
office. The Directors to retire are those who have been longest in office since their last election. A Director who
retires by rotation under clause 14.2 is eligible for re-election.
6 |
The Company currently has 3 Directors (excluding the Managing Director) and accordingly 1 must retire.
Mr Steve Gostlow, the Director longest in office since his last re-election, retires by rotation and seeks re-election
as a Director.
Steve has over 20 years’ experience in the waste management industry. He was the Managing Director of Tox Free
Solutions Ltd (Toxfree) for 16 years where he developed Toxfree into one of Australia’s largest waste management
companies. Steve has formal governance qualifications as a Graduate of the Australian Institute of Company
Directors as well as significant expertise in waste treatment, waste treatment technologies and regulatory
compliance. Steve has also worked as an Environmental Scientist in the mining sector as well as the State
Government of Western Australia. Steve is Chair of the Remuneration and Nomination Committee and a member
of the Audit and Risk Committee
If Resolution 2 is passed, Steve Gostlow will be re-elected to the Board as a Non-executive Director.
If Resolution 2 is not passed, Steve Gostlow will not be re-elected to the Board as a Non-executive Director. The
Board would retain sufficient directors to ensure it can make a quorum at meetings of Directors and would not be
required constitutionally to appoint a new Director.
The Board (with Mr Gostlow abstaining) unanimously supports the re-election of Mr Gostlow.
RESOLUTION 3: Adoption of Employee Incentive Securities Plan
General
Resolution 3 seeks Shareholder approval for the adoption of the employee incentive plan titled “Employee
Incentive Securities Plain” (Incentive Plan) and for the issue of Securities under the Incentive Plan in accordance
with ASX Listing Rule 7.2 (Exception 13(b)).
The objective of the Incentive Plan is to attract, motivate and retain key employees and the Company considers
that the adoption of the Incentive Plan and the future issue of Securities under the Incentive Plan will provide
selected employees with the opportunity to participate in the future growth of the Company.
ASX Listing Rule 7.1 limits the amount of equity securities that a listed company can issue without the approval of
its shareholders over any 12 month period to 15% of the fully paid ordinary shares it had on issue at the start of
that period.
ASX Listing Rule 7.2 (Exception 13(b)) provides that ASX Listing Rule 7.1 does not apply to an issue of securities
under an employee incentive scheme if, within three years before the date of issue of the securities, the holders
of the entity’s ordinary securities have approved the issue of equity securities under the scheme as exception to
ASX Listing Rule 7.1.
Exception 13(b) is only available if and to the extent that the number of equity securities issued under the scheme
does not exceed the maximum number set out in the entity’s notice of meeting dispatched to shareholders in
respect of the meeting at which shareholder approval was obtained pursuant to ASX Listing Rule 7.2 (Exception
13(b)). Exception 13(b) also cease to be available if there is a material change to the terms of the scheme from
those set out in the notice of meeting.
If Resolution 3 is passed, the Company will be able to issue Securities under the Incentive Plan to eligible
participants over a period of 3 years. The issue of any Securities to eligible participants under the Incentive Plan
will be excluded from the calculation of the number of equity securities that the Company can issue without
Shareholder approval under ASX Listing Rule 7.1.
For the avoidance of doubt, the Company must seek Shareholder approval under Listing Rule 10.14 in respect of
any future issues of Securities under the Incentive Plan to a related party or a person whose relationship with he
Company or the related party is, in ASX’s opinion, such that approval should be obtained.
7 |
If Resolution 3 is not passed, the Company will be able to proceed with the issue of Securities under the Incentive
Plan to eligible participants, but any issues of Securities will reduce, to that extent, the Company’s capacity to issue
equity securities without Shareholder approval under ASX Listing Rule 7.1 for the 12 month period following the
issue of the Securities.
Technical Information required by ASX Listing Rule 7.2 (Exception 13)
Pursuant to and in accordance with ASX Listing Rule 7.2 (Exception 13), the following information is provided in
relation to Resolution 3:
(a) a summary of the key terms and conditions of the Share Plan is set out at Appendix 1 to this notice.
(b) the Company has previously issued 14,296,714 securities under its previous incentive plan – Performance
Rights and Option Plan and Incentive Share Plan, by way of:
a. 13,671,714 Performance Shares;
b. 625,000 Unlisted Options exercisable at prices between $0.20 and $0.30; and
c.
525,000 Fully Paid Ordinary Shares.
(c) A maximum number of securities that are proposed to be issued under the Incentive Plan is the maximum
permitted under s1100V of the Corporations Act 2001, being 5% of the Company’s issued capital at the
time of the offer. As of the date of this meeting, that number of shares is 10,786,045.
RESOLUTION 4: Approval of 7.1A Mandate
General
ASX Listing Rule 7.1A provides that an Eligible Entity may seek Shareholder approval at its annual general meeting
to allow it to issue Equity Securities up to 10% of its issued capital over a period up to 12 months after the annual
general meeting (10% Placement Capacity).
An Eligible Entity is one that, as at the date of the relevant annual general meeting:
(a)
is not included in the S&P/ASX 300 Index; and
(b)
has a maximum market capitalisation (excluding restricted securities and securities quoted on a deferred
settlement basis) of $300,000,000.
The Company is an Eligible Entity as it is not included in the S&P/ASX 300 Index and has a current market
capitalisation of approximately $6.04 million.
Any Equity Securities issued must be in the same class as an existing class of quoted Equity Securities. The
Company currently has one class of quoted Equity Securities on issue, being the Shares (ASX Code: DEL).
If Shareholders approve Resolution 4, the number of Equity Securities the Eligible Entity may issue under the 10%
Placement Capacity will be determined in accordance with the formula prescribed in ASX Listing Rule 7.1A.2.
The effect of Resolution 4 will be to allow the Directors to issue Equity Securities up to 10% of the Company’s fully
paid ordinary securities on issue under the 10% Placement Capacity during the period up to 12 months after the
Meeting, without subsequent Shareholder approval and without using the Company’s 15% annual placement
capacity granted under ASX Listing Rule 7.1.
Resolution 4 is a Special Resolution. Accordingly, at least 75% of votes cast by Shareholders present and eligible
to vote at the Meeting must be in favour of Resolution 4 for it to be passed.
If Resolution 4 is passed, the Directors will be able to issue up to 10% of the Company’s fully paid ordinary share
securities on issue under the 10% placement capacity during the period of up to 12 months after the approval.
8 |
If Resolution 4 is not passed, the Directors will not be able to issue up to 10% of the Company’s fully paid ordinary
share securities on issue under the 10% placement capacity during the period of up to 12 months after the
approval.
The exact number of Equity Securities that the Company may issue under an approval of Listing Rule 7.1A will be
calculated according to the following formula contained within that Listing Rule.
Technical information required by ASX Listing Rule 7.1A
Pursuant to and in accordance with ASX Listing Rule 7.3A, the information below is provided in relation to this
Resolution 4:
Minimum Price
(a)
The minimum price at which the Equity Securities may be issued is 75% of the volume weighted average price of
Equity Securities in that class, calculated over the 15 ASX trading days on which trades in that class were recorded
immediately before:
(i)
the date on which the price at which the Equity Securities are to be issued is agreed; or
(ii)
if the Equity Securities are not issued within 10 ASX trading days of the date above, the date on
which the Equity Securities are issued.
Date of Issue
(b)
The Equity Securities may be issued under the 10% Placement Capacity commencing on the date of the Meeting
and expiring on the first to occur of the following:
(c)
(i)
12 months after the date of this Meeting;
(ii)
the time and date of the entity’s next annual general meeting; and
(iii)
the time and date of approval by Shareholders of any transaction under ASX Listing Rules 11.1.2 or
11.2.
Risk of voting dilution
Any issue of Equity Securities under the 10% Placement Capacity will dilute the interests of Shareholders who do
not receive any Shares under the issue.
If Resolution 4 is approved by Shareholders and the Company issues the maximum number of Equity Securities
available under the 10% Placement Capacity, the economic and voting dilution of existing Shares would be as
shown in the table below.
The table on the following page shows the dilution of existing Shareholders calculated on the basis of the current
market price of Shares and the current number of Equity Securities on issue as at the date of this Notice.
The table also shows the voting dilution impact where the number of Shares on issue (variable A in the formula)
changes and the economic dilution where there are changes in the issue price of Shares issued under the 10%
Placement Capacity.
9 |
Dilution
Shares on issue
$0.014
$0.028
$0.056
50% decrease in
Issue Price
Issue Price
100% increase
in Issue Price
10% Voting
Dilution
21,572,091
Shares
21,572,091
Shares
21,572,091
Shares
Funds raised
$302,009
$604,019
$1,208,037
10% Voting
Dilution
32,358,137
32,358,137
32,358,137
Shares
Shares
Shares
Funds raised
$453,014
$906,028
$1,812,056
10% Voting
Dilution
43,144,183
43,144,183
43,144,183
Shares
Shares
Shares
Funds raised
$604,019
$1,208,037
$2,416,074
Variable A* in Listing
Rule 7.1A.2
Issue price per
Share
215,720,915 Shares
Current Variable A
323,581,373 Shares
50% increase in Current
Variable A
431,441,830 Shares
100% increase in Current
Variable A
* The number of Shares on issue (variable A in the formula) could increase as a result of the issue of Shares
that do not require Shareholder approval (such as under a pro-rata rights issue or scrip issued under a
takeover offer) or that are issued with Shareholder approval under ASX Listing Rule 7.1.
The table above uses the following assumptions:
(a)
The current shares on issue are the Shares on issue as at 16 October 2023;
(b)
No options are exercised into Shares before the date of issue of the Equity Securities;
(c)
The 10% voting dilution reflects the aggregate percentage dilution against the issued share capital
at the time of issue. That is why the voting dilution is shown in each example as 10%;
(d)
The issue price set out above is the closing price of the Shares on the ASX on 13 October 2023;
(e)
The Company issues the maximum possible number of Equity Securities under the 10% Placement
Capacity;
(f)
The Company has not issued any Equity Securities in the 12 months prior to the Meeting that were
not issued under an exception in ASX Listing Rule 7.2 or with approval under ASX Listing Rule 7.1;
(g)
The calculations above do not show the dilution that any one particular Shareholder will be subject
to. All Shareholders should consider the dilution caused to their own shareholding depending on
their specific circumstances; and
(h)
This table does not set out any dilution pursuant to approvals under ASX Listing Rule 7.1.
Shareholders should note that there is a risk that:
(d)
(i)
the market price for the Company’s S
Share your feedback
Discover